Drug Details
General Information of the Drug (ID: DR8626) | ||||
---|---|---|---|---|
Name |
GM-CSF
|
|||
Molecular Type |
Protein
|
|||
Disease | Acute myelogenous leukemia [ICD-11: 2A41] | Approved | [1] | |
DrugBank ID |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. A List of Natural Product(s) Able to Enhance the Efficacy of This Drug | ||||||
Arsenic trioxide | Realgar and orpiment | Click to Show/Hide the Molecular Data of This NP | ||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [2] | |||||
Detail(s) | Combination Info click to show the detail info of this combination | |||||
Molecule(s)
Regulation |
Up-regulation | Phosphorylation | JAK-2 | Molecule Info |
Pathway MAP
|
|
Down-regulation | Expression | PML | Molecule Info |
Pathway MAP
|
||
Down-regulation | Expression | RARA | Molecule Info |
Pathway MAP
|
||
In-vitro Model | NB4 | CVCL_0005 | Acute promyelocytic leukemia | Homo sapiens | ||
UF-1 | CVCL_0567 | Acute promyelocytic leukemia | Homo sapiens | |||
In-vivo Model | Human GM-CSF-producing trans genic SCID (hGMTgSCID) mice were pretreated with 3 Gy of total body irradiation and then inoculated subcutaneously with UF-1 cells (1 * 107 cells) in their logarithmic growth phase. | |||||
Experimental
Result(s) |
A combination of As2O3 and GM-CSF induces differentiation of APL cells both in vitro and in vivo. |
Target and Pathway | ||||
---|---|---|---|---|
Target(s) | GMCSFR-alpha (CSF2RA) | Molecule Info | [3] | |
KEGG Pathway | Cytokine-cytokine receptor interaction | Click to Show/Hide | ||
2 | Jak-STAT signaling pathway | |||
3 | Hematopoietic cell lineage | |||
4 | Pathways in cancer | |||
NetPath Pathway | IL3 Signaling Pathway | Click to Show/Hide | ||
2 | RANKL Signaling Pathway | |||
Pathway Interaction Database | GMCSF-mediated signaling events | Click to Show/Hide | ||
2 | Alpha9 beta1 integrin signaling events | |||
Reactome | GPVI-mediated activation cascade | Click to Show/Hide | ||
2 | G beta:gamma signalling through PI3Kgamma | |||
3 | Interleukin-3, 5 and GM-CSF signaling | |||
4 | RAF/MAP kinase cascade | |||
5 | Surfactant metabolism | |||
6 | Interleukin receptor SHC signaling | |||
WikiPathways | Interleukin-2 signaling | Click to Show/Hide | ||
2 | Interleukin-3, 5 and GM-CSF signaling |